Related Experiment Video
Updated: May 9, 2026

Drug Treatment and In Vivo Imaging of Osteoblast-Osteoclast Interactions in a Medaka Fish Osteoporosis Model
Published on: January 1, 2017
Zoledronic acid inhibits human osteoblast activities
Fernanda G Basso1, Ana Paula Silveira Turrioni, Josimeri Hebling
1Piracicaba School of Dentistry, UNICAMP - Universidade de Campinas, Piracicaba, Araraquara, Brazil.
Zoledronic acid (ZA) significantly harms human osteoblasts, reducing their viability and function. This bisphosphonate impacts bone health by decreasing protein production and mineralization, crucial for bone matrix synthesis.
Area of Science:
- Biomedical Science
- Cell Biology
- Pharmacology
Background:
- Bisphosphonates are vital for treating bone resorption disorders.
- Oral osteonecrosis is a known side effect, particularly in older patients.
- Cytotoxicity of bisphosphonates on osteoblasts is implicated in oral osteonecrosis.
Purpose of the Study:
- To investigate the long-term effects of zoledronic acid (ZA) on human osteoblasts in vitro.
- To assess ZA's impact on osteoblast function and viability.
Main Methods:
- Human osteoblasts (MG63) were cultured and exposed to zoledronic acid (ZA) for 7, 14, or 21 days.
- Evaluated cell viability, total protein production, alkaline phosphatase (ALP) activity, and mineral nodule formation (MNF).
- Assessed gene expression of ALP and osteocalcin (OCN), alongside cell morphology via scanning electron microscopy.
Main Results:
- Zoledronic acid (ZA) exhibited dose- and time-dependent cytotoxicity.
- Observed significant reductions in cell viability, protein production, ALP activity, and MNF.
- Noted alterations in osteoblast gene expression (ALP, OCN) and cell morphology.
Conclusions:
- Zoledronic acid (ZA) at 1 and 5 μM concentrations demonstrates significant cytotoxic effects on human osteoblasts.
- ZA impairs key functions in bone matrix synthesis and mineralization.
- These findings highlight ZA's detrimental impact on osteoblast activity.
Related Concept Videos
Osteoclasts in Bone Remodeling
Role of Vitamins in Maintaining Bone Health
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Bone Remodeling
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Acid Suppressive Drugs for Peptic Ulcer Disease: Antacids
However, this neutralization reaction between...
